HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xian-Rong Xu Selected Research

Lutein

3/2015Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.
1/2015Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration.
2/2014Effects of lutein and lycopene on carotid intima-media thickness in Chinese subjects with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
2/2013Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration.
1/2013Effects of lutein supplement on serum inflammatory cytokines, ApoE and lipid profiles in early atherosclerosis population.
11/2012Serum carotenoids in relation to risk factors for development of atherosclerosis.
11/2012Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
10/2012Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.
2/2012Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis.
1/2009Serum lutein and its dynamic changes during supplementation with lutein in Chinese subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xian-Rong Xu Research Topics

Disease

6Macular Degeneration (Age-Related Maculopathy)
03/2015 - 02/2012
3Atherosclerosis
02/2014 - 11/2012
2Gestational Diabetes (Gestational Diabetes Mellitus)
05/2022 - 02/2022
2Neoplasms (Cancer)
10/2014 - 06/2013
1Asphyxia (Suffocation)
05/2022
1Postpartum Hemorrhage
05/2022
1Polyhydramnios
05/2022
1Hypoglycemia (Reactive Hypoglycemia)
05/2022
1Proteinuria
05/2022
1Rupture
05/2022
1Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
05/2022
1Obesity
02/2022
1Overweight
02/2022
1Nasopharyngeal Carcinoma
10/2014
1Neoplasm Metastasis (Metastasis)
10/2014
1Otitis Media
10/2014
1Xerostomia
10/2014
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
06/2013
1Bone Resorption
08/2009
1Chronic Disease (Chronic Diseases)
01/2009
1Polyps
12/2006
1Infertility (Sterility)
12/2006

Drug/Important Bio-Agent (IBA)

10LuteinIBA
03/2015 - 01/2009
7ZeaxanthinsIBA
03/2015 - 02/2012
3Macular PigmentIBA
03/2015 - 11/2012
2Triglycerides (Triacylglycerol)IBA
02/2022 - 11/2012
2LipidsIBA
02/2022 - 01/2013
2Retinaldehyde (Retinal)IBA
03/2015 - 10/2012
2CytokinesIBA
01/2013 - 11/2012
1Shenqi JiangtangIBA
05/2022
1LycopeneIBA
02/2014
1Carcinoembryonic AntigenIBA
06/2013
1Oncogene Proteins (Oncogene Protein)IBA
06/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2013
1Biomarkers (Surrogate Marker)IBA
02/2013
1Apolipoproteins E (ApoE)IBA
01/2013
1Lipoproteins (Lipoprotein)IBA
01/2013
1Carotenoids (Carotene)IBA
11/2012
1Proteins (Proteins, Gene)FDA Link
08/2009
1Whey ProteinsIBA
08/2009
1Estrogen Receptor alphaIBA
12/2006
1Estrogen Receptor betaIBA
12/2006

Therapy/Procedure

1Cesarean Section (Caesarean Section)
05/2022
1Radiotherapy
10/2014
1Lymph Node Excision (Lymph Node Dissection)
06/2013
1Gastrectomy
06/2013
1Intrauterine Devices (Intrauterine Device)
12/2006